Is ranitidine necessary as premedication for regimens containing paclitaxel? A non-inferiority study-Reference-Cited by-同舟云学术

Is ranitidine necessary as premedication for regimens containing paclitaxel? A non-inferiority study

Published:2023-07-21 Issue:9 Volume:16 Page:877-883
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Montero Pérez Olalla¹^ORCID,Martinez Benavides Javier¹^ORCID,González Fernandez Tania²,Guerra Prio Silvia³,Romero Domínguez Rocío⁴,Mesía Nin Ricard⁵,Clopés Estela Ana¹

Affiliation:

1. Pharmacy Department, Catalan Institute of Oncology, Barcelona, Spain

2. Pharmacy Department, Catalan Institute of Oncology, Hospitalet de Llobregat, Spain

3. Pharmacy Department, Catalan Institute of Oncology, Girona, Spain

4. Pharmacy Department, Catalan Institute of Oncology, Badalona, Spain

5. Medical Oncology Department, Catalan Institute of Oncology, Badalona. B-ARGO Group, IGTP, Badalona, Spain

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2023.2238596

Reference31 articles.

1. European Public Assessment Report (EPAR). Paclitaxel. Ficha Técnica del medicamento. European Agency for the Evaluation of Medicinal Products (EMEA) [internet]. Available from: https://cima.aemps.es/cima/pdfs/es/ft/73010/FT_73010.pdf

2. Ranitidine-induced anaphylaxis: clinical features, cross-reactivity, and skin testing

3. Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction

4. Mechanisms of Hypersensitivity

5. Complement Activation by Cremophor EL as a Possible Contributor to Hypersensitivity to Paclitaxel: an In Vitro Study

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Switching the Histamine-1 Receptor Antagonist Clemastine to Cetirizine in Paclitaxel Premedication Regimens: The H1-Switch Study;JCO Oncology Practice;2024-09

2. Is a low dose of dexamethasone sufficient to prevent paclitaxel-related hypersensitivity reactions? A retrospective study in patients with gynecologic malignancy;Expert Review of Clinical Pharmacology;2024-04-23

3. Correction;Expert Review of Clinical Pharmacology;2023-08-17

4. Magen/Darm- und Lebererkrankungen;Arzneiverordnungs-Report 2023;2023